CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Reviews

Ninad Ramdasi 0 904 Article rating: No rating

In this edition, we have reviewed Pidilite Industries and GAIL (India). We suggest our reader-investors to HOLD in Pidilite Industries and GAIL (India)

Query Board

Ninad Ramdasi 0 957 Article rating: No rating

This section gives decisive investment rationales to our subscribers on the stock queries they have raised to our research team.

Zydus Cadila launches Remdesivir injection at Rs 2,800

Nidhi Jani 0 1850 Article rating: 3.5

A few other companies have also launched Remdesivir recently, which includes names like Cipla at a price of Rs 4,000 and Jubilant Life Sciences at Rs 4,700. Further, Dr Reddy is also expecting to launch Remdesivir in August 2020 and it has received a voluntary licence from Gilead Sciences to manufacture and distribute the said drug.

MF QueryBoard

Ninad Ramdasi 0 591 Article rating: No rating

Readers are requested to send only one query at a time so that more readers get a chance. Have questions relating to any aspect of personal finance. Ask DSIJ at editorial@DSIJ.in and get your queries resolved.

Can Active Funds Still Generate Alpha?

Ninad Ramdasi 0 928 Article rating: No rating

There has always been a tug of war between active and passive investors. There are dozens of studies carried out around the world that say that it is very difficult for an active fund manager to beat the index consistently. So, does this in any way mean that you should scrap the idea of investing in an actively managed fund? The report provides insights into this issue

SGX Nifty hints at bright start for markets

DSIJ Intelligence-3 0 1113 Article rating: 4.6

Indian markets are likely to open with a positive bias on Thursday aided by strong close on Wall Street overnight. At 7:50 am, SGX Nifty was up by 6.50 points trading at 11,317.50 levels. The zone of 11,340-11,380 is a stiff resistance for the bulls and as long as the index stays below this level do not expect a runaway rise. 

Welcome Move by RBI

Ninad Ramdasi 0 716 Article rating: No rating

It is a known fact that equity has always attracted greater attention than its distant cousin bond or debt when it comes to economic growth. The bond market, however, remains a key component of the financial system and its robustness and economic growth are positively correlated.

Franklin India Fund

Ninad Ramdasi 0 971 Article rating: No rating

I was holding units in Franklin India Ultra Short-Term Bond Fund, which I sold after they wrote off Vodafone Idea paper and before the creation of a segregated portfolio. Am I entitled for segregated portfolio units as this was written off from my holdings? And since this can neither be bought nor sold, should I not get the proceeds? What does the rule say?

CRISIL reaffirms rating on Jubilant FoodWorks commercial paper programme

DSIJ Intelligence 0 1493 Article rating: 5.0

CRISIL has reaffirmed its 'CRISIL A1+' rating on the commercial paper programme of Jubilant FoodWorks Limited. The rating continues to reflect an established market position in the quick-service restaurant (QSR) segment, healthy operating efficiency driven by a robust supply-chain network, and a strong financial risk profile.

Sensex gains by more than 200 points; IRCTC jumps by nearly 4 per cent; Trent slumps by more than 4 per cent

DSIJ Intelligence 0 1660 Article rating: 5.0

The Sensex closed today at 38407.01 by gaining 224.93 points or by 0.59 per cent whereas the Nifty registered 52.35 points or 0.46 per cent to settle at 11322.50. The metal, banking stock and pharma stock did well in today’s buying session.

IndiGo to raise up to Rs 4,000 crore via QIP; stock recovers from March low

DSIJ Intelligence 0 2046 Article rating: 4.8

InterGlobe Aviation, which runs one of India’s most popular airlines IndiGo, announced that the company’s board of directors has approved fundraising of up to Rs 4,000 crore through the issuance of equity shares by way of a qualified institutional placement (QIP).

Gufic Lifesciences signs pact with Hetero Labs for Remdesivir lyophilised powder

Apurva Joshi 1 3173 Article rating: 3.4

Gufic Lifesciences Private Limited (GLPL) has entered into a loan license agreement with Hetero Labs Limited to manufacture and supply Remdesivir lyophilised powder for injection (100 mg/vial) on loan license basis to Hetero for its sale in various countries, including India.

Index trend and stocks in action on August 11, 2020

DSIJ Intelligence-3 0 1329 Article rating: 4.2

As long as the resistance zone of 11,340-11,380 is not cleared convincingly, do not expect a run-away rise. On the downside, the level of 11,230 is likely to act as an immediate support level, followed by 11,120 levels. Stocks in news: Cupid, Titan, Suven Pharmaceuticals, Gufic Biosciences, BLS International Services, Kotak Mahindra Bank.

Sensex, Nifty close in green; Shilpa Medicare zooms by more than 11 per cent, Lupin jumps by nearly 9 per cent

DSIJ Intelligence 0 1325 Article rating: 3.3

Sensex on Monday gained by 141.51 points or 0.37 per cent to close at 38182.08 while Nifty rose by 60.65 points or 0.54 per cent to settle at 11274.70. The day saw pharma stocks like Cipla and Natco Pharma doing well.

Sensex, Nifty close flat amid volatile session; CG Power locks in at upper circuit, Deepak Nitrite tumbles by five per cent

DSIJ Intelligence 0 1311 Article rating: 4.2

Ending the week, domestic benchmark indices closed flat with a positive bias on Friday, as Sensex gained by a mere 0.04 per cent or 15.12 points to settle at 38,040.57 while Nifty rose by 0.12 per cent or by 13.90 points to reach the level of 11,214.05.

Prince Pipes rises 11.74 per cent on technical collaboration with Tooling Holland

DSIJ Intelligence 0 1288 Article rating: 3.4

Prince Pipes and Fittings Limited (PPFL), one of India’s largest integrated piping solutions & multi polymer manufacturers, announced that the company has entered into a technical collaboration with Tooling Holland BV, a global leader in the international plastic injection moulding industry based in the Netherlands.

Glenmark to launch higher strength version of oral antiviral FabiFlu

DSIJ Intelligence 0 1887 Article rating: 4.8

Global pharma major, Glenmark Pharmaceuticals announced on Thursday that it is launching a 400 mg version of oral antiviral FabiFlu, for the treatment of mild to moderate COVID-19 in India. Glenmark Pharmaceuticals was the first company in the country to have received the regulator’s approval for 400 mg dosage form.

Sensex, Nifty gain by nearly one per cent; Tata Communication locks in at upper circuit, Bata declines by over four per cent

DSIJ Intelligence 0 1266 Article rating: 5.0

On Thursday, with RBI's announcement of keeping the repo rate unchanged at four per cent, Sensex rose by 362.12 points or by 0.96 per cent to close at 38,025.45 while its NSE counterpart Nifty gained by 98.50 points or 0.89 per cent to end at 11,200.15.

RSS
First336337338339341343344345Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR